Summary
Introduction
Angiotensinogen, a plasma protein synthesized by the liver [ 1 I, is currently estimated by measuring Direct radioimmunoassay (RIA) of angiotensinogen has already been performed in humans [41 and a good correlation was shown between direct and indirect assays, except for subjects treated by oestrogens. However, no such direct assay has until now been developed for animals.
The complete purification of rat angiotensinogen earlier enabled us to produce highly specific antibodies against this protein [51. We described here a direct RIA of plasma angiotensinogen in rats in different physiological states. The results are compared with those obtained by measuring the angiotensin I generated in the presence of renin excess.
Materials and methods

Materials
Rat angiotensinogen from bilaterally nephrectomized rat plasma was purified to the stage of homogeneity [Sl. The angiotensin I content of the final preparation was 23 pg/mg of protein, corresponding to the expected theoretical specific activity of a molecule of angiotensinogen with a molecular weight of 57000 containing 1 mol of angiotensin I/mol of angiotensinogen. Other purity criteria included the presence of a single protein band in SDS/polyacrylamide gel electrophoresis and of a single arc on immunodiffusion by Ouchterlony's technique 161. Finally, the purity of the protein allowed identification of 17 amino acids of the N-terminal sequence.
Des-angiotensin I-angiotensinogen was prepared by incubating 10 nmol of pure angio- Blood samples for determination of rat plasma angiotensinogen were collected after decapitation of different groups of male Wistar rats, which included normal rats and rats treated with either ethinyl oestradiol (1 pmol/kg body weight per day for 5 days) or with dexamethasone (10 pmol/kg twice a day for 1 day). Three other groups were bilaterally nephrectomized, adrenalectomized and allowed to drink tap water, or surgically thyroidectomized 1, 7 or 45 days before decapitation respectively.
Plasma samples from man, monkey, dog, hog, rabbit and mouse were also collected for detection of possible cross-reactivity with rat angiotensinogen.
Methods
Antibodies were raised in three Fauve de Bourgogne rabbits by the method of Vaitukaitis et al. 181 . Rabbits were injected intradermally every 6 weeks with 1 nmol of pure rat angiotensinogen and the injections repeated five times. The animals were bled 2, 4 and 6 weeks after each injection and the serum was stored at -2OOC. The antisera titres were tested by their ability to bind 50% of pure lz5I-labelled angiotensinogen. Double immunodiffusion was performed by Ouchterlony's method 161. Direct angiotensinogen radioimmunoassay. Pure angiotensinogen (0.1 nmol) was iodinated by the method of Greenwood et al. t91 . Iodinated angiotensinogen was separated from free iodine on a Sephadex G-25 (Pharmacia) column (1 a 5 cm x 30 cm) and then applied to an Ultrogel AcA54 (LKB) column (1 cm x 100 cm). The latter was calibrated with albumin (Sigma), mol. wt. 67 000, ovalbumin (Miles), mol. wt. 43 000, and echymotrypsinogen (Sigma), mol. wt. 25 700.
A single symmetrical radioactive peak was eluted with a molecular weight of 59 OOO. The specific radioactivity calculated by the method of self displacement [ 101 with increasing tracer mass was 3 1 pCi/pg of protein.
Direct angiotensinogen radioimmunoassay was performed as follows: 100 pl of pure angiotensinogen (0.25-10 ng of protein) or l00pl of an appropriate dilution of plasma (ranging from 1:500 to 1:3OOO) was incubated with 200 pl of antiserum (1 : 5 5 OOO) and 200pl of Iz5I-labelled angiotensinogen (5000 c.p.m.) in phosphate buffer (0.1 mol/l) containing bovine serum albumin (Sigma) at 1 mg/ml, and EDTA (5 mmol/l), for 24 h at 4OC. Bound and free angiotensinogens were separated in the presence of 1 mg of bovine y-globulin (Sigma) by using 1 ml of 20% polyethylene glycol solution (mol. wt. 6000; Fluka) in phosphate buffer (0.1 mol/l), pH 7.5. The mixture was immediately centrifuged at 5000 g for 30 min at 4OC and the radioactivity of the precipitate was counted. Each assay was run in triplicate.
Indirect angiotensinogen assay. Angiotensinogen was incubated with an excess of mouse submaxillary gland renin, 20 x Goldblatt units (GU), and the angiotensin I liberated was measured by RIA, as described previously [21. Preliminary experiments confirmed that all the angiotensin I from the angiotensinogen was exhausted after 2 h of incubation with 20 x loT3 GU of renin.
Protein assays. Angiotensinogen concentrations were determined by the fluorescamine method [ 1 11. The standard curve was constructed with bovine serum albumin.
Statistical analysis. Results are expressed as means f SEM and statistical comparisons were made by analysis of variance [ 121.
Results
Production of angiotensinogen antibodies
Two out of the three rabbits produced angiotensinogen antibodies. Immunodiffusion gave a single precipitation line with no spur formation, indicating the homogeneity of the preparation (Fig. 1) . Final antibody titres were 1 : 100 OOO and 1 : 70 OOO respectively. presence of various amounts of pure unlabelled angiotensinogen. The sensitivity of the assay, corresponding to the limit of detection, was 5 fmol of angiotensinogen.
Angiotensinogen radioimmunoassay
A straight line parallel to the standard curve was obtained for various dilutions of normal plasma, indicating the immunological identity of this different source of angiotensinogen (Fig. 2) . Similar results were observed with plasma from ethinyl oestradiol-treated rats and bilaterally nephrectomized, thyroidectomized and adrenalectomized animals.
The intra-and inter-assay coefficients of variation were respectively 2% ( n = 20) and 17% ( n = 14).
Antibody speciJcity
No cross-reaction (<0402%) was found when the rat angiotensinogen-specific antibody was tested with angiotensin I, angiotensin I1 and the synthetic hog tetradecapeptide. A slight crossreaction (0.05%) occurred when mouse plasma was assayed with antiserum but angiotensinogen from the five other species tested did not cross-react (Table 1) . However, rat des-angiotensin I-angiotensinogen completely crossreacted with the angiotensinogen antibody.
Comparison of direct and indirect angiotensinogen RIA Fig. 3 shows that the values obtained with the direct radioimmunoassay for increasing amounts of pure angiotensinogen (determined by protein assay) were identical with those found by the indirect method (angiotensin I liberated in the presence of an excess of renin).
When angiotensinogen was measured in plasma it appeared that the difference between normal rats and rats under different physiological states was statistically significant by both direct and indirect assays, except for adrenalectomized animals measured by the direct method ( Table 2) . The direct assay consistently gave a higher value (12-13%) but the differences between the two assays in the treated groups of rats were not significantly different from that of normal animals, with the exception of the adrenalectomized rats. In the last-named group a major discrepancy was observed. The angiotensinogen level measured by the indirect method was very low (0-16 nmol of ANG I/ml) but was When angiotensinogen values obtained by the direct method were expressed in terms of those measured by the indirect assay it appeared that a regression line 0, = 1.25 x -0.04) could be drawn for all groups except for adrenalectomized rats (Fig. 4) .
Discussion
We report here the first radioimmunoassay of angiotensinogen from rat plasma with pure angiotensinogen and specific antibodies. Up till However, in the present work, no cross-reaction was observed between rat angiotensinogen antibodies and angiotensinogens from dog, hog, rabbit, monkey or man. The curve for rat plasma was parallel to the standard curve, a fact which clearly demonstrated the immunological identity of these two sources of rat angiotensinogen. The sensitivity of the assay (5 fmol) allowed determination of angiotensinogen in very minute quantities of plasma or biological fluids.
The regression line demonstrated a ratio of 1 (indirect): 1.2 (direct). In ethinyl oestradiol-treated rats we observed no discrepancy between the results for these two assay systems, contrary to the findings reported for certain women with elevated substrate level induced by oral contraceptives [41. This may be due to a species difference or to differences in the doses and the duration of treatment. However, the plasma angiotensinogen concentration was always higher for direct assay, and varied from 12 to 30% in the different groups, except in adrenalectomized rats (300%). This may have been due either to underestimation of angiotensin I, for the reasons indicated above, or to the presence in the plasma of a small quantity of des-angiotensin I-angiotensinogen, since the latter protein exhibited the same behaviour towards antibodies as angiotensinogen.
It is possible that des-angiotensin I-angiotensinogen increases in adrenalectomized rat plasma, which might explain the discrepancy between the values obtained by direct and indirect methods. Previous authors showed that adrenalectomy slightly increased the production of angiotensinogen synthesized by the isolated perfused liver, although the plasma angiotensinogen level was lower than the control content [MI. The reduction in plasma angiotensinogen observed with the indirect assay only might be due to a rise in substrate consumption resulting from the high levels of circulating renin found after adrenalectomy and the consequent enhancement of des-angiotensin I-angiotensinogen release. This discrepancy was not due to incomplete exhaustion by renin of the angiotensinogen-derived angiotensin I resulting from a high content of des-angiotensin I-angiotensinogen, smce the latter has been shown not to affect the rate of the reaction between renin and angiotensinogen in the rat [161 contrary to findings in the human 171.
We have developed a direct radioimmunoassay for rat angiotensinogen which has allowed us to suggest the presence of a large amount of des-angiotensinogen in adrenalectomized rat plasma.
